Global Electronic Health Record Market is Projected to Reach ~USD 54 Billion by 2032

By GlobeNewswire Published on June 11, 2025, 22:00 IST
New York, USA, June 11, 2025 (GLOBE NEWSWIRE) — Global Electronic Health Record Market is Projected to Reach ~USD 54 Billion by 2032 | DelveInsight
The electronic health records market is experiencing robust growth, primarily driven by the increasing incidence of chronic diseases that require ongoing monitoring, data management, and coordinated long-term care. This rising demand has led to a greater need for integrated healthcare systems capable of seamlessly sharing patient information across departments and care settings. In response, governments worldwide are introducing supportive policies, funding programs, and regulatory frameworks to boost EHR adoption and improve healthcare efficiency. At the same time, major industry players are ramping up innovation, launching advanced, user-friendly, and interoperable EHR solutions that leverage artificial intelligence and data analytics.
DelveInsight's Electronic Health Record Market Insights report provides the current and forecast market analysis, individual leading electronic health record companies' market shares, challenges, electronic health record market drivers, barriers, trends, and key market electronic health record companies in the market.
Key Takeaways from the Electronic Health Record Market Report As per DelveInsight estimates, North America is anticipated to dominate the global electronic health record market during the forecast period.
In the product & services segment of the electronic health record market, the software category captured a significant revenue share in 2024.
Notable electronic health record companies such as Epic Systems Corporation, Oracle, Veradigm LLC, Medical Information Technology, Inc., athenahealth, NXGN Management, LLC, eClinicalWorks, Greenway Health, LLC, Practice Fusion, Inc., Particle Health, Practice Fusion, Inc., American Well, Medisafe, GetWellNetwork, Inc., Personify Health, Luma Health Inc., CipherHealth Inc., Relatient, CureMD Healthcare, Oneview Healthcare, and several others are currently operating in the electronic health record market.
and several others are currently operating in the electronic health record market. In April 2025, Wolters Kluwer Health announced an expanded integration with the EHR company Epic, enabling UpToDate Enterprise customers and their patients to access patient education content directly within the Epic EHR and MyChart patient portal.
announced an expanded integration with the EHR company Epic, enabling UpToDate Enterprise customers and their patients to access patient education content directly within the Epic EHR and MyChart patient portal. In November 2024, Suki , a leader in AI technology for healthcare, announced partnerships with EHR providers MEDENT and Azalea Health. Both companies integrated Suki's AI engine, the Suki Platform, into their systems to enhance user experience and improve patient care.
, a leader in AI technology for healthcare, announced partnerships with EHR providers MEDENT and Azalea Health. Both companies integrated Suki's AI engine, the Suki Platform, into their systems to enhance user experience and improve patient care. In May 2024, Athenahealth announced the launch of athenaOne for Women's Health and athenaOne for Urgent Care.
To read more about how do electronic health records improve workflow processes, get a snapshot of the key highlights entailed in the Functions of Electronic Health Records
Electronic Health Record Overview
An electronic health record (EHR) is a digital version of a patient's paper chart and is designed to be accessed by authorized users across different healthcare settings. It contains comprehensive health information such as medical history, diagnoses, medications, immunization dates, allergies, lab results, and physician notes. Unlike traditional paper records, EHRs allow real-time, secure access to patient data, thereby improving coordination among healthcare providers, reducing errors, and facilitating more accurate diagnoses and treatment.
EHR systems also support better patient engagement and healthcare analytics. Patients can access their own health records through secure portals, empowering them to participate in their care. Meanwhile, healthcare providers can use EHR data for population health management, tracking outcomes, and improving efficiency. Despite these benefits, EHR implementation can face challenges such as high costs, interoperability issues between systems, and data privacy concerns. Nonetheless, EHRs are central to modern healthcare infrastructure and play a crucial role in advancing quality, safety, and patient-centered care.
Electronic Health Record Market Insights
North America led the electronic health record market in 2024, holding the largest market share. This leadership is primarily due to the rising incidence of chronic illnesses, largely stemming from an aging population. The region is also witnessing increased adoption of telehealth services and a growing emphasis on patient-centric care, both of which are driving market expansion. Moreover, advancements in technology and robust governmental support for digital health initiatives are significantly contributing to the growth of the EHR market in North America.
EHRs are essential in chronic disease management, enabling consistent, coordinated, and data-informed care. They help healthcare providers monitor patient conditions over time, track medication adherence, and detect health trends through real-time access to medical records, lab results, and treatment plans. Additionally, EHR systems support preventive care by issuing alerts for screenings, follow-up visits, and routine health checks, which helps reduce complications, hospital admissions, and emergency room visits, especially for patients with chronic conditions like diabetes, hypertension, and cardiovascular disease.
Leading companies in the region are also focusing on innovation to enhance their EHR offerings and strengthen their market presence. For instance, in May 2024, Athenahealth introduced athenaOne for Women's Health and athenaOne for Urgent Care, cloud-based, integrated solutions that combine EHR capabilities with practice management, revenue cycle tools, and patient engagement features. These tailored platforms aim to meet the unique needs of various medical specialties.
To know more about why the North America electronic health record (EHR) market is leading, get a snapshot of the Electronic Health Record Development
Electronic Health Records Market Dynamics
The electronic health record market is undergoing rapid transformation, driven by the convergence of technological advancements, healthcare digitization mandates, and growing demand for data interoperability. Governments around the world, especially in developed economies, are investing in digital healthcare infrastructure, with policies aimed at improving healthcare efficiency and patient outcomes. For instance, initiatives like the U.S. HITECH Act and the European Union's digital health strategies have accelerated EHR adoption among providers. As a result, hospitals, clinics, and physician practices are increasingly moving toward integrated EHR systems that can facilitate seamless access to patient data across various touchpoints.
A key dynamic shaping the EHR market is the growing need for interoperability and patient data portability. Historically, many EHR systems operated in silos, leading to fragmented patient records and care delays. Today, both regulators and healthcare providers are pushing for open APIs, FHIR standards, and cross-platform compatibility. This trend is fostering innovation among EHR vendors who now need to balance robust functionality with open architecture. Companies like Epic, Cerner (now part of Oracle), and athenahealth are continuously evolving their platforms to remain competitive in a market where connectivity and integration have become key differentiators.
Cloud adoption is another significant driver, as cloud-based EHR systems offer scalability, lower upfront infrastructure costs, and easier access for remote care. The rise of telemedicine and virtual care, accelerated by the COVID-19 pandemic, has underscored the need for accessible, real-time patient information. This has led smaller practices and large healthcare systems alike to transition from on-premise to SaaS-based EHR models. However, this shift also raises concerns around data security and compliance, particularly with HIPAA in the U.S. and GDPR in the EU, compelling vendors to invest in advanced cybersecurity features.
Despite these advancements, the EHR market continues to face challenges such as user dissatisfaction, high implementation costs, and workflow inefficiencies. Physicians often report that EHRs can be cumbersome, leading to increased administrative burdens. To counter this, there's growing interest in AI-driven tools and natural language processing (NLP) that can automate documentation, improve decision support, and enhance user experience. Vendors that prioritize user-centric design and clinical efficiency are likely to gain a competitive edge.
Overall, the EHR market is expected to grow steadily, but its trajectory will depend on how well stakeholders—vendors, providers, regulators—collaborate to address longstanding issues of usability, standardization, and data security. As healthcare continues to evolve into a more data-driven, value-based model, EHR systems will remain central to enabling coordinated care, population health management, and patient engagement.
Get a sneak peek of the benefits of using electronic health records @ Advantages and Disadvantages of Electronic Health Records Report Metrics Details Coverage Global Study Period 2022–2032 Electronic Health Records Market CAGR ~6% Electronic Health Records Market Size by 2032 USD 53.5 Billion Key Electronic Health Record Companies Epic Systems Corporation, Oracle, Veradigm LLC, Medical Information Technology, Inc., athenahealth, NXGN Management, LLC, eClinicalWorks, Greenway Health, LLC, Practice Fusion, Inc., Particle Health, Practice Fusion, Inc., American Well, Medisafe, GetWellNetwork, Inc., Personify Health, Luma Health Inc., CipherHealth Inc., Relatient, CureMD Healthcare, Oneview Healthcare, among others
Electronic Health Records Market Assessment Electronic Health Records Market Segmentation Electronic Health Records Market Segmentation By Product and Services: Hardware, Software, and Services Electronic Health Records Market Segmentation By Deployment: On-premise, Cloud, and Hybrid Electronic Health Records Market Segmentation By Application: Clinical Decision Making, Administrative Support, Patient Management, and Others Electronic Health Records Market Segmentation By End Users: Hospitals & Clinics, Ambulatory Surgical Centers, and Others Electronic Health Records Market Segmentation By Geography : North America, Europe, Asia-Pacific, and Rest of World
Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Which MedTech key players in the electronic health records market are set to emerge as the trendsetter explore @ Electronic Health Record Companies
Table of Contents 1 Electronic Health Record Market Report Introduction 2 Electronic Health Record Market Executive Summary 3 Competitive Landscape 4 Regulatory Analysis 5 Electronic Health Record Market Key Factors Analysis 6 Electronic Health Record Market Porter's Five Forces Analysis 7 Electronic Health Record Market Layout 8 Electronic Health Record Market Company and Product Profiles 9 KOL Views 10 Project Approach 11 About DelveInsight 12 Disclaimer & Contact Us
Interested in knowing how does electronic health records improve patient care? Click to get a snapshot of the Benefits of Electronic Health Records
Related Reports
Chronic Heart Failure Market
Chronic Heart Failure Market Insights, Epidemiology, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key CHF companies, including Cytokinetics, Bayer, Eli Lilly, BioCardia, Mesoblast, Tenax Therapeutics, Novo Nordisk, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Intra-Cellular Therapies, Cardurion Pharmaceuticals, Rivus Pharmaceuticals, among others.
Acute Coronary Syndrome Market
Acute Coronary Syndrome Market Insights, Epidemiology, and Market Forecast – 2034 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key ACS companies, including Novartis, Boehringer Idorsia Pharmaceuticals, Viatris, Recardio, AstraZeneca, Faraday Pharmaceuticals, DalCor Pharmaceuticals, Roche, Jiangsu Vcare PharmaTech, CeleCor Therapeutics, Novo Nordisk, Bristol Myers Squibb, Johnson & Johnson Innovative Medicine, CellProthera, BioCardia, Kancera, Amgen, Arrowhead Pharmaceuticals, Abcentra, among others.
Diabetes Market
Diabetes Market Insights, Epidemiology, and Market Forecast – 2034 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key diabetes companies, including Enthera, Nano Precision Medical, Oramed, Dompe Farmaceutici, Carmot Therapeutics, Scohia Pharma, Genexine, REMD Biotherapeutics, among others.
Type 1 Diabetes Market
Type 1 Diabetes Market Insights, Epidemiology, and Market Forecast – 2034 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key type 1 diabetes companies, including Histogen, Novo Nordisk, Prevention Bio, among others.
Type 2 Diabetes Market
Type 2 Diabetes Market Insights, Epidemiology, and Market Forecast – 2034 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key type 2 diabetes companies, including Sanofi, Eli Lilly and Company, AstraZeneca, Novartis, among others.
DelveInsight's Pharma Competitive Intelligence Service: Through its CI solutions, DelveInsight provides its clients with real-time and actionable intelligence on their competitors and markets of interest to keep them stay ahead of the competition by providing insights into the latest therapeutic area-specific/indication-specific market trends, in emerging drugs, and competitive strategies. These services are tailored to the specific needs of each client and are delivered through a combination of reports, dashboards, and interactive presentations, enabling clients to make informed decisions, mitigate risks, and identify opportunities for growth and expansion.
Other Business Pharmaceutical Consulting Services
Healthcare Conference Coverage
Pipeline Assessment
Healthcare Licensing Services
Discover how a mid-pharma client gained a level of confidence in their soon-to-be partner for manufacturing their therapeutics by downloading our Due Diligence Case Study
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Los Angeles Times

4 hours ago

• Los Angeles Times

Early-Stage Technology Disruptions and Trends Set to Define the Future of Business Systems

Researchers point to technologies addressing GenAI-enabled code architecture, disinformation security and surface asset management as the most likely to be widely adopted by businesses by 2030, while leaders find themselves reassessing cloud usage and not overlooking the ever-growing need for effective cybersecurity solutions Through its research and surveys of C-suiters, Gartner, Inc. has identified the most likely emerging technology disruptions that will impact businesses and define the future of business systems. Technology leaders are clearly prioritizing these over the next five years, as they present competitive opportunities in the near term and will eventually grow to become standard throughout businesses. 'Technology leaders must take action now to gain a first-mover advantage with these technologies,' said Bill Ray, distinguished VP analyst at Gartner. 'Innovative advancements like generative AI-enabled code architecture, disinformation security and Earth intelligence will provide the differentiation needed to help enterprises pull ahead of the pack in terms of data and product offerings.' Each disruptor is significant in its own right, but in combination, they start to define broader emerging solutions to new business practices. For example, advancing GenAI technologies will spawn new solutions around Earth intelligence and business simulation, spur the expansive growth of domainspecific language models and lead to higher functioning tools. GenAI solutions systems using free-form text and multimedia inputs/outputs will displace the conventional form-oriented sequential UI in established enterprise applications and enable new user scenarios. 'To remain competitive, traditional enterprise application software vendors will need to refactor applications to serve composable GenAI solutions that are invoked on demand via textual and multimodal prompts,' said Ray Valdes, VP analyst at Gartner. Because of this, Gartner predicts that by 2029, more than 50% of user interactions linked to enterprise business processes will leverage large language models to bypass the UI layer in traditional enterprise applications, up from less than 5% today. Disinformation security is an emerging discipline focused on threats from outside the corporate-controlled network. It includes a suite of technologies, such as deepfake detection, impersonation prevention and reputation protection, which can address disinformation to help enterprises discern trust, protect their brand and secure their online presence. Gartner predicts that by 2030, at least half of enterprises will have adopted products or services to address disinformation security, up from less than 5% in 2024. 'Disinformation attacks use external infrastructure, like social media, and originate from areas with limited legal oversight,' said Alfredo Ramirez IV, senior director analyst at Gartner. 'Tech leaders must add 'disinformation-proofing' to products by using AI/machine learning for content verification and data provenance tracking to help users discern the truth.' Gartner predicts that by 2028, 80% of major Earth surface assets globally will be monitored by active satellites. Earth intelligence tech uses AI to analyze satellite, aerial and ground data to monitor Earth's assets and activities, providing insights for decision-making. 'That doesn't mean maps and charts. Earth intelligence is delivering numbers on global nickel production, theme park revenue and the health of wheat crops, to name just a few,' said Ray. Given the breadth of applications, Earth intelligence is applicable to all industries and enterprises. Defense has been the first adopter, but improvements in the quality of data and analysis techniques have rapidly expanded the use cases. The Earth intelligence market is now divided between those who capture the data, those who interpret and analyze it and those who generate industry-specific insights. 'Earth intelligence applies to every business,' said Ray. 'Enterprises can gain an early advantage by creatively and strategically applying Earth intelligence to significantly enhance specific functionalities of existing systems or to compete via new net capabilities.' In a separate research report, Gartner has also announced the top trends shaping the future of cloud adoption over the next four years. These include cloud dissatisfaction, AI/machine learning (ML), multicloud, sustainability, digital sovereignty and industry solutions. Joe Rogus, director, advisory at Gartner, said, 'These trends are accelerating the shift in how cloud is transforming from a technology enabler to a business disruptor and necessity for most organizations. Over the next few years, cloud will continue to unlock new business models, competitive advantages and ways of achieving business missions.' Cloud adoption continues to grow, but not all implementations succeed. Gartner predicts 25% of organizations will have experienced significant dissatisfaction with their cloud adoption by 2028, due to unrealistic expectations, suboptimal implementation and/or uncontrolled costs. To remain competitive, enterprises need a clear cloud strategy and effective execution. Gartner research indicates that those who have successfully addressed upfront strategic focus by 2029 will find their cloud dissatisfaction will decrease. Gartner also predicts 50% of cloud computing resources will be devoted to AI workloads by 2029, up from less than 10% today. 'This all points to a fivefold increase in AI-related cloud workloads by 2029,' said Rogus. 'Now is the time for organizations to assess whether their data centers and cloud strategies are ready to handle this surge in AI and ML demand. In many cases, they might need to bring AI to where the data is to support this growth.' Many organizations that have adopted multicloud architecture find connecting to and between providers a challenge. This lack of interoperability between environments can slow cloud adoption, with Gartner predicting more than 50% of organizations will not get the expected results from their multicloud implementations by 2029. Gartner recommends identifying specific use cases and planning for distributed apps and data in the organization that could benefit from a cross-cloud deployment model. This enables workloads to operate collaboratively across different cloud platforms, as well as different onpremises and colocation facilities. AI adoption, tightening privacy regulations and geopolitical tensions are also driving demand for sovereign cloud services. Organizations will be increasingly required to protect data, infrastructure and critical workloads from control by external jurisdictions and foreign government access. Gartner predicts over 50% of multinational organizations will have digital sovereign strategies by 2029, up from less than 10% today. 'As organizations proactively align their cloud strategies to address digital sovereignty requirements, there are already a wide range of offerings that will support them,' said Rogus. 'However, it's important they understand exactly what their requirements are, so they can select the right mix of solutions to safeguard their data and operational integrity.' With all the talk of businesses onboarding GenAI and other emerging technology solutions, it's easy to overlook cybersecurity tools. CEOs, however, are not forgetting to lock the proverbial door. Gartner's research has shown that a whopping 85% of CEOs surveyed say that cybersecurity is critical for business growth moving forward. In a survey of 456 CEOs and other senior business executives, 61% of CEOs are concerned about cybersecurity threats, driven in large part by AI's growing role in commercial activity and the political debates about the sourcing and use of advanced technologies. As risk thresholds shift, they view cybersecurity as a key driver. 'Cybersecurity is no longer just about protection; it's a critical driver for business growth,' said David Furlonger, distinguished vice president analyst and Gartner fellow. 'With 85% of CEOs recognizing its importance, security leaders have a unique opportunity to demonstrate the value of cybersecurity investments not only in safeguarding assets but also in enabling strategic business objectives.' 'Effective communication is key,' said Furlonger. 'CEOs should highlight the role of security leaders in both protecting the business and enhancing cybersecurity to drive growth. This involves, for example, assessing risks in foreign markets and intellectual property protection. Security leaders are positioned to significantly influence value generation, and they should communicate how cybersecurity aids enterprise growth.' With regulatory changes and cybersecurity threats challenging competitiveness, CEOs said they see a direct linkage between cybersecurity capabilities and enterprise growth. Meanwhile, C-suiters' comfort level with AI is far from established at this point. Only 44% of CIOs are deemed by their CEOs to be 'AI-savvy' according to the Gartner data. The survey revealed that 77% of CEOs believe that AI is indeed ushering in a new business era, yet they feel their organization's leading technology experts lack the knowledge and capabilities to support, drive or accelerate business outcomes in this evolving landscape. 'We have never seen such a disproportionate gap in CEOs' impressions about technological disruption,' said Furlonger. 'AI is not just an incremental change from digital business. AI is a step change in how business and society work. A significant implication is that if savviness across the C-suite is not rapidly improved, competitiveness will suffer and corporate survival will be at stake.' CEOs perceive even the CIO, chief information security officer (CISO) and chief data officer (CDO) as lacking AI savviness. CEOs highlighted that the top two limiting factors impacting AI's deployment and use are the inability to hire adequate numbers of skilled people and an inability to calculate value or outcomes. 'CEOs have shifted their view of AI from just a tool to a transformative way of working,' said Jennifer Carter, principal analyst at Gartner. 'This change has highlighted the importance of upskilling. As leaders recognize AI's potential and its impact on their organizations, they understand that success isn't just about hiring new talent. Instead, it's about equipping their current employees with the skills needed to seamlessly incorporate AI into everyday tasks.'

Business Upturn

16 hours ago

• Business Upturn

INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN DIEGO, June 21, 2025 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Tempus AI, Inc. (NASDAQ: TEM) common stock between August 6, 2024 and May 27, 2025, both dates inclusive (the 'Class Period'), have until August 12, 2025 to seek appointment as lead plaintiff of the Tempus AI class action lawsuit. Captioned Shouse v. Tempus AI, Inc. , No. 25-cv-06534 (N.D. Ill.), the Tempus AI class action lawsuit charges Tempus AI and certain of Tempus AI's top executives with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the Tempus AI class action lawsuit, please provide your information here: You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected]. CASE ALLEGATIONS: Tempus AI is a technology company advancing precision medicine through the practical application of artificial intelligence, including generative AI. The Tempus AI class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) Tempus AI inflated the value of contract agreements, many of which were with related parties, included non-binding opt-ins and/or were self-funded; (ii) the credibility and substance of Tempus AI's joint venture with SoftBank Group Corporation was at risk because it gave the appearance of 'round-tripping' capital to create revenue for Tempus AI; (iii) Tempus AI-acquired Ambry Genetics Corporation had a business model based on aggressive and potentially unethical billing practices that risked scrutiny and unsustainability; (iv) AstraZeneca PLC had reduced its financial commitments to Tempus AI through a questionable 'pass-through payment' via a joint agreement between it, Tempus AI, and Pathos AI, Inc.; and (v) the above issues revealed weakness in core operations and revenue prospects. The Tempus AI class action lawsuit further alleges that on May 28, 2025, Spruce Point Capital Management, LLC issued research report on Tempus AI that raised numerous red flags over Tempus AI's management, operations, and financial reporting. On this news, the price of Tempus AI stock fell more than 19%, according to the complaint. THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased Tempus AI common stock during the Class Period to seek appointment as lead plaintiff in the Tempus AI class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Tempus AI class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Tempus AI class action lawsuit. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Tempus AI class action lawsuit. ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases – more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information: Past results do not guarantee future outcomes. Services may be performed by attorneys in any of our offices. Contact: Robbins Geller Rudman & Dowd LLP J.C. Sanchez, Jennifer N. Caringal 655 W. Broadway, Suite 1900, San Diego, CA 92101 800-449-4900 [email protected]

Yahoo

a day ago

• Yahoo

How Local Economic Development Act funds help New Mexico businesses grow

NEW MEXICO (KRQE) – For years, state and city grant funding has been used to grow businesses in New Mexico with the goal of keeping jobs here and boosting the economy. One local business who has expanded over the years said it's all thanks to that local funding. Vitality Works, located in Albuquerque, makes dietary and herbal supplements. 'We are the guys that really make the stuff for over 600 brands in the United States. Our name is on nothing, but we make other people's goods and fully package turnkey operations,' said Vitality Works CEO/Founder Mitch Coven. Coven said since he started his company in the 1980's, it's far surpassed his goals. He said the growth wouldn't have been possible without money from grants and tax credits. 'Everything that the city, county, state has made available to us has helped foster our growth even faster,' added Coven. One of the grants he's received is through the Local Economic Development Act, or LEDA which was signed into New Mexico law in the early 90's to incentivize and support growing businesses. 'We want the public sector to be an enabling partner that allows those entrepreneurs and those companies to be successful,' said Director of Economic Development for the City of Albuquerque Max Gruner. Vitality Works is just one company that's benefited from LEDA in the metro. In just the past eight years, the city of Albuquerque has committed more than $13.7 million in LEDA funding to help grow and retain 15 businesses. Those who qualify are expected to show how their company will expand, create jobs and have a local economic impact. 'We are really trying to use the mechanism of these incentives to create generational wealth for our families in Albuquerque,' said Gruner. Vitality Works produces 50,000 bottles of supplements and more a day. Coven believes his company is a way to give back to New Mexico as he employs more than 300 people and he sources some herbs in the state. His company is receiving it's second LEDA funding, which he hopes to use to expand the company even further by adding another 30,000 square feet to his facility. 'Our plans are to keep capturing the growth. We have to keep expanding,' said Coven. State LEDA funds are appropriated by the legislature, while participating cities also have their own LEDA funds, which are controlled by city councils. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data